Seven NSAIDs were compared in the analysis: four selective COX2 inhibitors (celecoxib, etoricoxib, rofecoxib and lumiracoxib) and three traditional NSAIDs (naproxen, ibuprofen and diclofenac).

A study published in the European Heart Journal showed that patients who were prescribed anti-inflammatory drugs (NSAID) like ...

Rofecoxib and lumiracoxib were associated with the highest risk of MI (rate ratio: 2.12 and 2.00; 95% CI: 1.26–3.56 and 0.71–6.21, respectively); Ibuprofen and diclofenac were associated with ...

It has also been shown to be at least as effective as naproxen, ibuprofen, ketorolac and diclofenac. [14] The quick-release formulation, designed to obtain a high peak plasma concentration ...